Table VI.

Percent burn wound contraction of topical formulations

	% Wound contraction
Formulation base	4th day	8th day	12th day
	Control %	27.61 ± 1.33a	53.31 ± 1.22a	67.03 ± 0.92a
Carbopol %	52.17 ± 1.56a	75.10 ± 1.73a	88.11 ± 0.63a
Carbopol # %	31.03 ± 1.84a	58.13 ± 0.37a	70.10 ± 0.92a
PEG %	49.14 ± 1.67a	70.13 ± 0.12a	81.10 ± 0.47a
PEG # %	30.02 ± 1.30v	56.34 ± 0.24a	65.31 ± 0.73a
HPMC %	47.23 ± 1.73a	63.46 ± 1.17a	72.15 ± 0.76a
HPMC # %	30.10 ± 0.72a	48.01 ± 0.29a	58.03 ± 0.29a
Ointment %	44.15 ± 1.73a	60.01 ± 0.32a	67.45 ± 0.15a
Ointment # %	29.01 ± 0.93a	57.13 ± 0.29a	61.00 ± 0.27a
Silver Sulfadiazine 1% cream, USP	52.00 ± 1.45a	71.87 ± 0.98a	84.34 ± 0.49a

^#Represents the group treated with base alone

^ap < 0.001 vs. Control